MYLAN PHARMACEUTICALS INC

Company Type: Manufacturer

Company Introduction:

Mylan Pharmaceuticals Inc. was a global pharmaceutical company primarily focused on the development, manufacturing, and marketing of a broad range of generic and specialty pharmaceutical products. Established in 1961, it grew to become one of the world's largest producers of generic drugs.

The company's core operations involved significant research and development capabilities, state-of-the-art manufacturing facilities, and a robust global supply chain. Its product portfolio spanned numerous therapeutic areas, including antiretrovirals for HIV/AIDS, cardiovascular health, central nervous system disorders, oncology, respiratory conditions, and women's health. Mylan was dedicated to providing access to high-quality, affordable medicine to patients worldwide.

With a strong presence across North America, Europe, Asia, and other key markets, Mylan established itself as a significant player in the global pharmaceutical industry. Its business model emphasized vertical integration, controlling aspects from active pharmaceutical ingredient (API) production to finished dosage forms.

In November 2020, Mylan N.V. (the parent company of Mylan Pharmaceuticals Inc.) merged with Upjohn, Pfizer's off-patent branded and generic established medicines business, to form a new global healthcare company called Viatris Inc. Therefore, Mylan Pharmaceuticals Inc. no longer operates as an independent entity but is now part of Viatris.

Mylan Pharmaceuticals Inc., which is now part of Viatris, manufactured and sold a diverse portfolio of generic and specialty pharmaceutical products across numerous therapeutic areas.

Key product categories and examples of products include:

Cardiovascular Health

Atorvastatin Calcium, Lisinopril, Amlodipine Besylate, Metoprolol Tartrate, Valsartan.

Central Nervous System

Sertraline Hydrochloride, Gabapentin, Alprazolam, Clonazepam, Bupropion Hydrochloride.

Gastrointestinal

Pantoprazole Sodium, Omeprazole, Famotidine.

Anti-infectives

Doxycycline Hyclate, Amoxicillin, Azithromycin.

Pain Management and Inflammation

Ibuprofen, Naproxen, Tramadol Hydrochloride.

Respiratory

Albuterol Sulfate Inhalation Solution, Fluticasone Propionate.

Women's Health

Various oral contraceptive formulations.

Oncology

Generic versions of several chemotherapy agents.

Specialty Pharmaceuticals

EpiPen and EpiPen Jr (epinephrine auto-injectors).

Biosimilars

Biosimilar versions of complex biological drugs, including those for oncology and immunology, such as biosimilar Trastuzumab, Adalimumab, and Insulin Glargine.

Other Therapeutic Areas

Products addressing diabetes, dermatology, and ophthalmic conditions.